A CDC analysis noted that between 2021 and 2022, the age-adjusted rate of drug overdose deaths did not change significantly, a variation from previous years where the rates climbed overall. However,...
On March 19, 2024, AstraZeneca entered into a definitive agreement to acquire Fusion Pharmaceuticals in a $2 billion deal. Through this deal, AstraZeneca will expand its portfolio and gain access to...
A meeting of the United States FDA Oncologic Drugs Advisory Committee (ODAC) voted to expand the approval of Abecma and Carvykti, two types of chimeric antigen receptor (CAR) T-cell therapies, for...
Amazon Pharmacy will now be filling prescriptions for glucagon-like peptide-1 (GLP-1) drugs — and other pharmaceuticals for obesity, diabetes, and migraines — requested through Eli...
On March 11, 2024, the United States FDA issued a press release announcing its request for $7.2 billion from the president’s fiscal year (FY) 2025 budget, increasing its FY 2023 request by 7.4%...
On March 6, 2024, Valisure, an independent quality assurance lab, issued a press release identifying harmfully high levels of benzoyl peroxide in multiple skincare products, specifically products...
On March 8, 2024, the United States FDA expanded approval of Wegovy (semaglutide), making it the first weight loss drug that is FDA-approved for obese and overweight patients at high risk for heart...
Earlier this week, the World Health Organization (WHO) issued a news release stating that there are increased trends in human immunodeficiency virus (HIV) drug resistance to dolutegravir. Despite this...
On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients,...
On March 4, 2024, Perrigo Company, the manufacturer of Opill, announced that a monthly supply of the hormonal birth control pill costs $19.99 and is now available for pre-order. The product — and...
On Wednesday, February 28, 2024, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend that individuals ages 65 and older get an additional dose of the 2023–2024...
On February 26, 2024, Amgen announced it opened its latest manufacturing site in New Albany, Ohio, located in Central Ohio. The recently established facility stands out as a cornerstone in Amgen's...
A recent study published in Pediatrics, the journal of the American Academy of Pediatrics (AAP), revealed a significant increase in antidepressant prescriptions among adolescents, teens, and young...
On Wednesday, February 21, 2024, the NIH launched a clinical trial network for evaluating new cancer detection technologies or methods called the Cancer Screening Research Network (CSRN), which will...
On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at...
Last week, the CDC updated data on respiratory syncytial virus (RSV) vaccine uptake in the United States, revealing that almost half of infants in the US have been vaccinated. Additional data provided...
Adding to existing pancreatic cancer treatment options, the United States FDA granted Ipsen Biopharmaceuticals approval for Onivyde — generically known as irinotecan liposome — for treating...
On Monday, February 12, 2024, Gilead Sciences, a major pharmaceutical manufacturer, announced its plans to acquire CymaBay Therapeutics, a clinical-stage biopharmaceutical company with a strong liver...
In a heated Senate hearing on February 8th, the CEOs of Bristol Myers Squibb, Johnson & Johnson, and Merck faced rigorous questioning from various United States senators regarding the exorbitant...
Earlier this week, researchers revealed that approximately 10% of premature births in the United States are linked to prenatal phthalate exposure in a study published in the Lancet Planetary...
